Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Electronic Device Detects Molecules Linked to Cancer, Alzheimer's, Parkinson's

May 20, 2016 10:07 am | by FAPESP | News | Comments

A biosensor developed by researchers at the National Nanotechnology Laboratory (LNNano) in Campinas, São Paulo State, Brazil, detects molecules associated with neurodegenerative diseases and some types of cancer.

TOPICS:

UN: Life Expectancy Worldwide Has Increased By 5 Years

May 20, 2016 10:02 am | by Associated Press | News | Comments

Life expectancy worldwide has increased by about five years in the last 15 years according to a report by the World Health Organization in the fastest gain since the 1960s.

Heart Defect Prediction Technology could Lead to Earlier Treatment

May 20, 2016 9:57 am | by Cincinnati Children's Hospital Medical Center | News | Comments

An experimental model uses genetics-guided biomechanics and patient-derived stem cells to predict what type of inherited heart defect a child will develop, according to authors of a new study in the journal Cell.

TOPICS:
Advertisement

Mechanism that Reduces Effect of Cocaine on Brain Discovered

May 20, 2016 9:51 am | by McGill University Health Centre | News | Comments

The finding offers hope for development of a new approach to prevent drug use relapses.

TOPICS:

Lab Cell Study: HOXA5 Protein Acts as Tumor Suppressor in Breast Cancer

May 20, 2016 9:44 am | by John Hopkins Medicine | News | Comments

Researchers show that cells without HOXA5 have an increased capacity to renew themselves and are more invasive than normal breast cells.

TOPICS:

Amgen Subsidiary Identifies Gene Variation That Lowers Heart Attack Risk

May 20, 2016 9:38 am | News | Comments

The variant was discovered through the analysis of whole genome and clinical data from across the population of Iceland.

TOPICS:

How Depression and Antidepressant Drugs Work

May 20, 2016 9:35 am | by Penn State | News | Comments

The researchers plan to use their mouse model to better understand how ketamine functions to develop safer alternatives.

TOPICS:

New Company Created Novel Technology to Treat Diabetes

May 19, 2016 1:00 pm | by University of Aberdeen | News | Comments

The technology could bring the option of an islet transplant to thousands more patients with type 1 diabetes.

TOPICS:
Advertisement

Making Injectable Medicine Safer

May 19, 2016 9:34 am | by University at Buffalo | News | Comments

Researchers have tried to address this problem in two ways, each with varying degrees of success.

TOPICS:

Oramed Says Oral Insulin Succeeds in Midstage Type 2 Diabetes Trial

May 19, 2016 9:33 am | by Bill Berkrot, Reuters | News | Comments

The result is likely to surprise many skeptics who did not believe insulin could be delivered orally.

TOPICS:

Team Develops New MRSA-Fighting Antibiotic

May 19, 2016 9:33 am | by University of Oklahoma | News | Comments

The new drug to treat MRSA combines traditional Food and Drug Administration-approved antibiotics with the polymer BPEI.

TOPICS:

Universal Flu Vaccine Under Development by Oxford Spinout Vaccitech

May 19, 2016 9:32 am | by University of Oxford | News | Comments

Currently, no single vaccine can give immunity against even a majority of circulating flu virus strains.

TOPICS:

Small Peptide Therapeutics, Big Analytical Considerations

May 19, 2016 9:12 am | by Bo Kowalczyk, M.S, MBA, Vice President of Business Development, AIT Bioscience | Articles | Comments

Over the past decade, new strategies in peptide design have launched a wave of peptide therapeutics. Currently, there are approximately 140 peptide therapeutics in clinical development with over 500 in preclinical development, and the commercial market for novel innovative peptide therapeutics is expected to increase to $17.0 billion by 2018.

TOPICS:

Immune Drug for Deadly Skin Cancer Shows Long-Term Survival

May 19, 2016 9:07 am | by Lindsay Tanner, AP Medical Writer | News | Comments

A new kind of drug for the deadliest form of skin cancer helped some patients survive for at least three years, a study shows. 

TOPICS:

BMS Announces Positive Phase 3 Study Results for Opdivo

May 19, 2016 8:33 am | News | Comments

Findings to be presented at the meeting will also include additional research to explore biomarkers that may help predict outcomes with Opdivo.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading